PALO ALTO, Calif., December 8, 2016 — Rubrik, the world’s first Cloud Data Management Company, announced today that Fujirebio Diagnostics has deployed Rubrik’s comprehensive data management platform, replacing its legacy backup infrastructure with an all-in-one scalable solution that drives down cost, reduces complexity and can support the demands of its business.
As the world leader in the production of in vitro diagnostics and biomarkers, Fujirebio Diagnostics serves physicians, laboratory professionals, and patients through a network of partners and distributors worldwide. When the company made the shift to a 100 percent virtualized environment a few years ago, its legacy system became inconsistent and unable to keep up with the demands of its businesses. Switching to Rubrik, Fujirebio Diagnostics eliminated its complex tape backup processes using the public cloud and reduced its total cost of ownership by 75 percent.
“Rubrik stood out among the other solutions we evaluated for two reasons. First, the speed of recovery is phenomenal, allowing us to be up and running again in minutes, not days,” said Tim Gable, Network Systems Manager, Fujirebio Diagnostics. “Second, Rubrik has helped eliminate tape complexity and costs by instantly archiving all our mission critical production systems to the cloud, giving us more resiliency in case of a failure.”
While Fujirebio Diagnostics has seen tremendous improvements in their backup process, they’ve also benefited from Rubrik’s search and instant recovery features for DevOps. Using Rubrik’s platform, Fujirebio Diagnostics’ IT team is able to easily test how new applications perform before pushing for system wide updates. In addition to using Rubrik at its main data center in Pennsylvania, the company intends to deploy Rubrik Edge, a software only appliance for remote offices, in its facility in Texas, allowing them to extend the capabilities of Rubrik’s cloud data management platform to support even more of its business.
“Fujirebio Diagnostics plays a vital role in the healthcare industry, providing doctors with the tools they need to effectively diagnose patients,” said Bipul Sinha, co-founder and CEO, Rubrik. “By providing them with a scalable platform to manage all their backup and recovery needs, we ensure their IT team is spending less time managing the backup process and more time focusing on mission critical projects that drive results for their company.”
Rubrik has developed the world’s first Cloud Data Management platform for data protection, search, analytics, archival and copy data management for hybrid cloud enterprises. Fortune 500 companies use Rubrik to manage data at scale while realizing data-driven services anytime, anywhere. Rubrik has been named to Gartner’s Cool Vendors in Storage Technologies, 2016 and recognized by Forbes as a Next Billion Dollar Startup. For more information, visit http://www.rubrik.com and follow @rubrikInc on Twitter.
About Fujirebio Diagnostics
Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, manufacturing and commercialization of in-vitro diagnostic products for the management of human disease states, with an emphasis in oncology. Fujirebio Diagnostics is one of the group companies of Miraca Holdings, Inc., in Japan, set up in July 2005 to combine Fujirebio Inc., the leading in-vitro diagnostics company, and SRL, Inc., the top provider of clinical laboratory testing services in Japan. Fujirebio Diagnostics has a worldwide distribution network, which enables physicians and patients to access its diagnostic products. For more information about Fujirebio Diagnostics, please call 610-240-3800 or visit www.fdi.com.